Sign In
Buy PSTV
$5.42
-0.0500 (-0.91%)
At Close: Jun 03, 2026
Hot Penny Stocks To Buy For Under $1 Right Now
11:38am, Monday, 29'th Aug 2022
Penny stocks under $1 to watch this week. The post Hot Penny Stocks To Buy For Under $1 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Plus Therapeutics to Present Data from ReSPECT-GBM™ Clinical Trial at the European Society for Medical Oncology Congress 2022
07:00am, Tuesday, 23'rd Aug 2022
AUSTIN, Texas, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics
Why Is Plus Therapeutics (PSTV) Stock Up 56% Today?
11:04am, Thursday, 18'th Aug 2022
Source: CI Photos / Shutterstock.com Plus Therapeutics (NASDAQ: PSTV ) stock is in the news Thursday as investors react to the company getting a $17.6 million grant. That Product Development Research
Cheap Penny Stocks to Buy Now? 3 To Watch in August
06:00am, Thursday, 18'th Aug 2022
Here's what you need to know about buying penny stocks on August 18th The post Cheap Penny Stocks to Buy Now? 3 To Watch in August appeared first on Penny Stocks to Buy, Picks, News and Information |
Why Is Plus Therapeutics (PSTV) Stock Up 38% Today?
12:48pm, Monday, 15'th Aug 2022
Source: Shutterstock / PopTika Plus Therapeutics (NASDAQ: PSTV ) stock is climbing higher on Monday after the company revealed a stock buyback program. According to a press release from the company, i
AUSTIN, Texas, July 28, 2022 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics
Plus Therapeutics to Present at Inaugural Targeted Radiopharmaceuticals Summit
07:00am, Wednesday, 27'th Jul 2022
AUSTIN, Texas, July 27, 2022 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics
Plus Therapeutics, Inc. (PSTV) CEO Dr. Marc Hedrick on Q2 2022 Results - Earnings Call Transcript
07:55pm, Thursday, 21'st Jul 2022
Plus Therapeutics, Inc. (NASDAQ:PSTV ) Q2 2022 Results Conference Call July 21, 2022 5:00 PM ET Company Participants Dr. Marc Hedrick - President and Chief Executive Officer Dr. Norman LaFrance - Chie
Plus Therapeutics to Announce Second Quarter 2022 Financial Results and Host Conference Call on July 21, 2022
07:00am, Wednesday, 13'th Jul 2022
AUSTIN, Texas, July 13, 2022 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics
Biocept enters into comprehensive laboratory services agreement with Plus Therapeutics for cancer trial
09:11am, Wednesday, 22'nd Jun 2022
Biocept Inc (NASDAQ:BIOC) and Plus Therapeutics Inc have announced a comprehensive laboratory services agreement for Plus Therapeutics' ReSPECT-LM trial for the treatment of cancer in the membranes t
Plus Therapeutics to Present Virtually at the 2022 HC Wainwright Global Investment Conference
07:00am, Wednesday, 18'th May 2022
AUSTIN, Texas, May 18, 2022 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficu
3 Stocks Under $1 Insiders Are Aggressively Buying
08:04am, Friday, 29'th Apr 2022
US crude oil futures traded higher this morning on Friday. Investors, meanwhile, focused on some notable insider trades.
Plus Therapeutics to Present at the 2022 Q2 Investor Summit
07:00am, Tuesday, 26'th Apr 2022
AUSTIN, Texas, April 26, 2022 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and diffi
Plus Therapeutics to Announce First Quarter 2022 Financial Results and Host Conference Call on April 21, 2022
07:00am, Thursday, 14'th Apr 2022
AUSTIN, Texas, April 14, 2022 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics
Plus Therapeutics, Inc. (PSTV) CEO Marc Hedrick on Q4 2021 Results - Earnings Call Transcript
11:09pm, Thursday, 24'th Feb 2022
Plus Therapeutics, Inc. (PSTV) CEO Marc Hedrick on Q4 2021 Results - Earnings Call Transcript
